Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis.

Meltzer EO.

Ann Allergy Asthma Immunol. 2007 Jan;98(1):12-21. Review.

PMID:
17225715
2.

Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis.

Wingertzahn MA, Derebery MJ, Nelson HS.

Allergy Asthma Proc. 2007 May-Jun;28 Suppl 1:S18-24. Review.

PMID:
18307840
3.

Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis.

Mahadevia PJ, Shah S, Leibman C, Kleinman L, O'Dowd L.

Ann Allergy Asthma Immunol. 2004 Oct;93(4):345-50.

PMID:
15521370
5.

Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review.

Stanaland BE.

Clin Ther. 2004 Apr;26(4):473-92. Review.

PMID:
15189745
6.

Assessment of intranasal corticosteroid use in allergic rhinitis: benefits, costs, and patient preferences.

Dupclay L Jr, Doyle J.

Am J Manag Care. 2002 Sep;8(13 Suppl):S335-40. Review.

8.

Intranasal corticosteroids topical characteristics: side effects, formulation, and volume.

Petty DA, Blaiss MS.

Am J Rhinol Allergy. 2013 Nov-Dec;27(6):510-3. doi: 10.2500/ajra.2013.27.3949.

PMID:
24274228
9.

Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids.

Blaiss MS.

Curr Med Res Opin. 2008 Mar;24(3):821-36. doi: 10.1185/030079908X253780. Epub 2008 Feb 6. Review.

PMID:
18257976
10.
11.
12.

Intranasal corticosteroids for allergic rhinitis.

Trangsrud AJ, Whitaker AL, Small RE.

Pharmacotherapy. 2002 Nov;22(11):1458-67. Review.

PMID:
12432972
13.
15.

The role of nasal corticosteroids in the treatment of rhinitis.

Meltzer EO.

Immunol Allergy Clin North Am. 2011 Aug;31(3):545-60. doi: 10.1016/j.iac.2011.05.004. Review.

PMID:
21737042
16.

Intranasal steroid sprays in the treatment of rhinitis: is one better than another?

Waddell AN, Patel SK, Toma AG, Maw AR.

J Laryngol Otol. 2003 Nov;117(11):843-5. Review.

PMID:
14670141
17.

Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.

Derendorf H, Meltzer EO.

Allergy. 2008 Oct;63(10):1292-300. doi: 10.1111/j.1398-9995.2008.01750.x. Review.

18.

Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?

Keith PK, Scadding GK.

Curr Med Res Opin. 2009 Aug;25(8):2021-41. doi: 10.1185/03007990903094106. Review. Erratum in: Curr Med Res Opin. 2010 Jan;26(1):177. Curr Med Res Opin. 2010 Apr;26(4):990.

PMID:
19569975
19.

Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.

Nathan RA.

Ann Allergy Asthma Immunol. 2003 Feb;90(2):182-90; quiz 190-1, 232. Review.

PMID:
12602664
20.

Supplemental Content

Support Center